Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: Results from two double-blind, multicenter, placebo-controlled clinical trials

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Canafax, Daniel M ^a   Bhanegaonkar, Abhijeet ^b   Bharmal, Murtuza ^c,d   Calloway, Michael ^e  

^a XenoPort Inc   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (China)

^d IQVIA   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN ENACARBIL; PLACEBO; 1 (((ALPHA ISOBUTANOYLOXYETHOXY)CARBONYL)AMINOMETHYL) 1 CYCLOHEXANEACETIC ACID; 1-(((ALPHA-ISOBUTANOYLOXYETHOXY)CARBONYL)AMINOMETHYL)-1-CYCLOHEXANEACETIC ACID; 4 AMINOBUTYRIC ACID; CARBAMIC ACID DERIVATIVE; DRUG DERIVATIVE;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INTERNATIONAL RESTLESS LEG SCALE; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME STUDY SCALE SLEEP; MULTICENTER STUDY; PATIENT ATTITUDE; POST SLEEP QUESTIONNAIRE; PROFILE OF MOOD STATES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; RESTLESS LEGS SYNDROME QUALITY OF LIFE; VALIDATION STUDY; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSIOLOGY; PSYCHOMETRY; REPRODUCIBILITY; SLEEP; STATISTICS; TREATMENT OUTCOME;

ADULT; AGED; CARBAMATES; DOUBLE-BLIND METHOD; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESTLESS LEGS SYNDROME; SLEEP; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 79955143060     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-48     Document Type: Article

References (24)

1. Hening WA, Allen RP, Washburn M, Lesage SR, Earley CJ. The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics"). Sleep Med 2009, 10:976-981. 10.1016/j.sleep.2008.09.015, 2769267, 19185537.
2. Thomas K, Watson CB. Restless legs syndrome in women: a review. J Women's Health 2008, 17:859-868. 10.1089/jwh.2007.0515, 21525164.
3. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119. 10.1016/S1389-9457(03)00010-8, 14592341.
4. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalance of Restless Legs Syndrome among men aged 18 to 64 years of age: An assessment with somatic disease and neuropsychiatric symptoms. Mov Disord 2001, 16:1159-1163. 10.1002/mds.1209, 11748753.
5. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004, 5:237-246. 10.1016/j.sleep.2004.03.006, 15165529.
6. United States Food and Drug Administration Guidance for industry. Patient-reported outcome measures: Use in medical product development. 2009, United States Food and Drug Administration., http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf
7. Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW, . XP052 Study Group Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology 2009, 72:439-446. 10.1212/01.wnl.0000341770.91926.cc, 19188575, XP052 Study Group.
8. Lee D, Ziman R, Perkins AT, Poceta JS, Walters A, Barrett R. Randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome (RLS) [abstract]. Neurology 2009, 72(Suppl 3):A337.
9. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
10. Guy W. Clinical global impressions (CGI). Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology 1976, 2172-2222. U.S. Department of Health, Education, and Welfare, National Institute of Mental Health, Psychopharmacology Research Branch: Rockville, MD, Revised.
11. Hening WA, Allen RP. Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Medicine 2003, 4:95-97. 10.1016/S1389-9457(03)00009-1, 14592339.
12. Curran SL, Andrykowski MA, Studts JL. Short form of the Profile of Mood States: Psychometric information. Psychology Assessment 1995, 7:80-83.
13. Hays RD, Stewart AL. Sleep Measures. Measuring functioning and well-being: the Medical Outcomes Study approach 1992, 235-259. Durham, NC: Duke University Press, Stewart AL, Ware JE.
14. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study sleep measure. Sleep Med 2005, 6:41-44. 10.1016/j.sleep.2004.07.006, 15680294.
15. Hays R, Revicki DA. Reliability and validity (including responsiveness). Assessing Quality of Life in Clinical Trials 2005, 25-39. New York: Oxford University Press, Fayers P, Hays R, 2.
16. Allen RP, Kosinski M, Hill-Zabala CE, Calloway MO. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale in restless legs syndrome. Sleep Med 2009, 10:531-539. 10.1016/j.sleep.2008.06.003, 18805054.
17. Abetz L, Arbuckle R, Allen RP, Mavraki E, Kirsch J. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes 2005, 3:79. 10.1186/1477-7525-3-79, 1322229, 16329756.
18. Abetz L, Vallow SM, Kirsch J, Allen RP, Washburn T, Earley CJ. Validation of the Restless Legs Syndrome Quality of Life questionnaire. Value Health 2005, 8:157-167. 10.1111/j.1524-4733.2005.03010.x, 15804324.
19. Carmines EG, Zeller RA. Reliability and validity assessment. Sage University Paper Series on Quantitative Applications in the Social Sciences, 07-017 1979, Newbury Park, CA: Sage.
20. Cohen J. Statistical power analysis for the behavioral sciences 1988, Hillsdale: Lawrence Erlbaum Associates.
21. Cramér H. Mathematical Methods of Statistics 1999, Princeton, NJ: Princetown University Press.
22. Kruskal W, Wallis K. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952, 47:583-621.
23. Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ 1986, 134:889-895. 1490966, 3955482.
24. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987, 40:171-178. 10.1016/0021-9681(87)90069-5, 3818871.